Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoin

Hong Kong Med J. 2018 Aug;24(4):408-415. doi: 10.12809/hkmj187215.

Abstract

In 2016, meetings of groups of physicians and paediatricians with a special interest in lipid disorders and familial hypercholesterolaemia were held to discuss several domains of management of familial hypercholesterolaemia in adults and children in Hong Kong. After reviewing the evidence and guidelines for the diagnosis, screening, and management of familial hypercholesterolaemia, consensus was reached on the following aspects: clinical features, diagnostic criteria, screening in adults, screening in children, management in relation to target plasma low-density lipoprotein cholesterol levels, detection of atherosclerosis, lifestyle and behaviour modification, and pharmacotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anticholesteremic Agents / therapeutic use*
  • Cardiovascular Diseases / prevention & control
  • Child
  • Consensus
  • Disease Management
  • Humans
  • Hyperlipoproteinemia Type II / diagnosis*
  • Hyperlipoproteinemia Type II / drug therapy*
  • Practice Guidelines as Topic

Substances

  • Anticholesteremic Agents